Jon P Stonehouse insider trades: Biocryst Pharmaceuticals (BCRX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Jon reports to the SEC
Open-market buys and sales
22 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 13, 2024 | BCRX | ↑ Buy | 30,000 | $5.55 | $167K | Direct | May 15, 2024 (2d) |
| Feb 1, 2023 | BCRX | ↓ Sell | 100,000 | $10.38 | $1.0M | Direct | Feb 2, 2023 (1d) |
| Dec 15, 2022 | BCRX | ↓ Sell | 14,100 | $10.90 | $154K | Direct | Dec 19, 2022 (4d) |
| Dec 2, 2022 | BCRX | ↓ Sell | 297,573 | $12.94 | $3.9M | Direct | Dec 2, 2022 (0d) |
| Jan 11, 2022 | BCRX | ↓ Sell | 184,000 | $15.04 | $2.8M | Direct | Jan 13, 2022 (2d) |
| Dec 15, 2020 | BCRX | ↓ Sell | 134,278 | $8.32 | $1.1M | Direct | Dec 17, 2020 (2d) |
| Nov 18, 2019 | BCRX | ↑ Buy | 50,000 | $1.45 | $73K | Direct | Nov 18, 2019 (0d) |
| Dec 3, 2018 | BCRX | ↓ Sell | 80,000 | $9.12 | $730K | Direct | Dec 6, 2018 (3d) |
| Nov 9, 2018 | BLCM | ↑ Buy | 10,000 | $4.56 | $46K | Direct | Nov 13, 2018 (4d) |
| Jun 19, 2015 | BCRX | ↓ Sell | 20,000 | $15.02 | $300K | Direct | Jun 22, 2015 (3d) |
| Mar 2, 2012 | BCRX | ↓ Sell | 2,721 | $4.78 | $13K | Direct | Mar 5, 2012 (3d) |
| Aug 8, 2011 | BCRX | ↑ Buy | 10,000 | $2.52 | $25K | Direct | Aug 9, 2011 (1d) |
| Mar 18, 2011 | BCRX | ↑ Buy | 10,000 | $3.40 | $34K | Direct | Mar 18, 2011 (0d) |
| Jan 30, 2009 | BCRX | ↑ Buy | 3,000 | $1.61 | $5K | Direct | Feb 3, 2009 (4d) |
| Dec 1, 2008 | BCRX | ↑ Buy | 55,000 | $1.48 | $81K | Direct | Dec 2, 2008 (1d) |
| Nov 3, 2008 | BCRX | ↑ Buy | 25,000 | $1.75 | $44K | Direct | Nov 3, 2008 (0d) |
| Aug 12, 2008 | BCRX | ↑ Buy | 2,300 | $3.10 | $7K | Direct | Aug 13, 2008 (1d) |
| Aug 11, 2008 | BCRX | ↑ Buy | 7,700 | $2.95 | $23K | Direct | Aug 13, 2008 (2d) |
| Aug 4, 2008 | BCRX | ↑ Buy | 240 | $2.82 | $677 | Direct | Aug 4, 2008 (0d) |
| Jan 31, 2008 | BCRX | ↑ Buy | 3,000 | $3.50 | $11K | Direct | Feb 4, 2008 (4d) |
| Aug 14, 2007 | BCRX | ↑ Buy | 9,900 | $9.90 | $98K | Direct | Aug 14, 2007 (0d) |
| Jul 31, 2007 | BCRX | ↑ Buy | 2,463 | $7.05 | $17K | Direct | Aug 2, 2007 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other BCRX insiders
Open-market trades in the last 12 months
About Jon P Stonehouse's insider trades
Jon P Stonehouse is a director at Biocryst Pharmaceuticals (BCRX). Since Jul 31, 2007, Jon has reported 14 open-market purchases worth $630K and 8 sales worth $10.0M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (46 filings), shares withheld for taxes (24 filings), option exercises (17 filings), gifts (6 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BCRX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.